Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05013723 · ClinicalTrials.gov registry record
Impact of Monoclonal Antibody Treatment on Post-Acute COVID-19 Syndrome
A clinical trial, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 260
- Enrollment target
NCT05013723 is a clinical trial that has completed, run by Intermountain Health Care. The registered enrollment target is 260 participants.
The verdict
NCT05013723 has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
Use the Intermountain real-world MAb-treatment registry and control group to prospectively evaluate PACS symptoms at least 60 days after initial COVID-19 diagnosis.
Interventions
- OTHER Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2022-12-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05013723
The ClinicalTrials.gov registry entry for NCT05013723 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Surveys is the first listed.
NCT05013723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05013723 about?
NCT05013723 is a clinical study titled "Impact of Monoclonal Antibody Treatment on Post-Acute COVID-19 Syndrome". Use the Intermountain real-world MAb-treatment registry and control group to prospectively evaluate PACS symptoms at least 60 days after initial COVID-19 diagnosis.
What is the current status of trial NCT05013723?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2021-08-30. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT05013723?
The interventions under investigation include: Surveys (OTHER).
Who is sponsoring clinical trial NCT05013723?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.